News
Press ReleaseKing's College London spins out Korecyte Bio Ltd with investment and support from Cell and Gene Therapy Catapult to advance novel CAR-T platform for solid tumours
Plasticell, Cell and Gene Therapy Catapult and Imperial College London obtain funding to develop manufacturing platform for allogeneic cell immunotherapiesRegulatory Round-up - July 2023Cell and Gene Therapy Catapult appoints Jeanette Evans as Chief Business OfficerCell and Gene Therapy Catapult to support the development of NK:IO’s natural killer cell therapyThe Advanced Therapies Apprenticeship Community welcomes its 300th apprenticeRegulatory Round-up - June 2023Cell and Gene Therapy Catapult nominated for Innovation of the Year Award at the British Training AwardsAutolomous and the Cell and Gene Therapy Catapult awarded £1.2m grant by UK Research and InnovationCell and Gene Therapy Catapult opens new laboratories and offices in Edinburgh BioQuarterRegulatory Round-up - May 2023Science, not fiction - How a disruptive innovation is helping the advanced therapies sector gear up to the challenge of bringing T Level science students into their laboratories - by bringing the laboratories into their classroomsCell and Gene Therapy Catapult and the MHRA collaborate on adeno-associated virus reference material pilot study to support development of gene therapies